Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether allopurinol reduces left ventricular hypertrophy in patients with treated hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: University of Dundee | Conditions: Hypertension, Hypertrophy, Left Ventricular | Phase 4 | Status: COMPLETED